AI: Digital to Physical | BEYOND Expo 2026 Leads Transformative Global Direction of Tech
MACAO, May 31, 2026 /PRNewswire/ -- The BEYOND Expo 2026 has shown what the future looks like as it delivers on its mission of 'Empowering Asia, Bridging the World' with a heavyweight showcase of the latest emerging technology and ideas from Asia....
Golden Goblet Competition Lineup Announced: Spotlight on the 2026 Contenders
SHANGHAI, May 31, 2026 /PRNewswire/ -- The 28th Shanghai International Film Festival (SIFF) has officially unveiled the competition selections for the 2026 Golden Goblet Awards. Held from June 12 to 21, the Festival received approximately 4,100...
Dizal Presents Positive NSCLC Data for Fourth-Generation EGFR TKI DZD6008 and Golidocitinib in Combination with Anti-PD-1 at ASCO 2026
Oral presentation of DZD6008 demonstrated strong and durable anti-tumor activity, excellent BBB-penetrant properties, and a favorable safety profile in patients relapsed from third-generation EGFR TKI In treatment-naive patients with advanced NSCLC...
Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC Published in The Lancet
CHENGDU, China, May 31, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company", 6990.HK) announced today that the results of the Phase III clinical study OptiTROP-Lung05, evaluating the company's trophoblast...
Cyient Enters Agreement to Acquire TAO Digital
Acquisition enhances Cyient's offering portfolio with AI-native data and lifecycle engineering capabilities to drive data-readiness & digital transformation for its customers HYDERABAD, India, May 31, 2026 /PRNewswire/ -- Cyient Limited, a...
THE KILLERS ROCK THE UEFA CHAMPIONS LEAGUE FINAL KICK OFF SHOW PRESENTED BY PEPSI®
Millions of fans from across the world tuned in to watch the iconic rock band's unmissable performance ahead of the showpiece fixture of the club football season. BUDAPEST, Hungary, May 31, 2026 /PRNewswire/ -- #PEPSIKICKOFFSHOW – Global superstars...
The Results of Phase III OptiTROP-Lung05 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ASCO Oral Presentation and Simultaneously Published in The Lancet
CHENGDU, China, May 30, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company", 6990.HK) announced today that at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, the results of the Phase...
Kelun-Biotech Presents Pivotal Phase II Data for Lunbotinib Fumarate (A400/EP0031) in RET Fusion-Positive NSCLC at 2026 ASCO
CHENGDU, China, May 30, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company", 6990.HK) announced that at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, USA, results from the...